Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient fo...(our medicine-based portfolio which is fo...),Health
Navigation Links
Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
Date:11/13/2007
our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.
Media Materials
For images and video related to Novartis Vaccines & Diagnostics please visit http://www.thenewsmarket.com/novartisvaccines. Journalists may register and download print-quality images and broadcast-standard video from this site at no charge.
Novartis Media Relations
Beth Birke
Novartis Vaccines and Diagnostics
Global Communications
+1-617-871-4281
e-mail: media.relations@novartis.com or nvd.communications@novartis.com
'/>"/>
| SOURCE Novartis Vaccines Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ
6. Combination vaccines okay for infants, study shows
7. Leave That Holiday To Do List in a Drawer
8. American Council on Exercise Offers 10 Tips for Surviving the Holidays
9. Make a Difference This Holiday Season
10. Marriage & Family: Celebrating Holiday Traditions
11. Have a Heart-Healthy Holiday
Post Your Comments:
(Date:1/8/2009)...ules of sugar sitting on the surface of cancer cel...med at both treating and stopping the spread of ce...clude prostate, breast, ovarian and lung, among ot...0 from the Gateway for Cancer Research, an Illinoi...ssandra Franco, M.D., Ph.D., and her co-workers at...
(Date:1/8/2009)... Allscripts Prenatal Solution Key Factor in Decisi...GO and ORLANDO, Fla., Jan. 8 /PRNewswire-FirstCall...ociates LLC, one of the largest multi-specialty gr...selected the Allscripts Enterprise(TM) Electronic ...80 physicians in 18 offices across Central Florida...
(Date:1/8/2009)...dreds of local dance students will dance to raise ...INNEAPOLIS, Jan. 8 , , , WH...rs will show off their talent in the 3rd annual Da...ted by Dance Arts Centre. The, ev... anchor., Participants raise mon...
(Date:1/8/2009)... SAN FRANCISCO, Jan. 8 M... that David Hung, M.D., president and chief,execu... Morgan Healthcare,Conference on Wednesday, Janua...t. Francis Hotel in San Francisco. , Dr. Hu...clinical,development programs for Dimebon for Alz...
Breaking Medicine News(10 mins):Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Dance With Courage to Benefit Camp Courage 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2[0] Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot'[0] Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians[0] Dance With Courage to Benefit Camp Courage[0] Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
...ts have developed a new minimally invasive method ... trials on individuals with prostate cancer soon ....le electroporation (IRE) is a result of the effort...r Rafael V. Davalos and University of California b...
...anners with standard commercial software designed ...ing coronary artery disease in as many as 40 perce..., professor in the Division of Cardiology at The U...ouston, said he discovered the abnormalities upon ...
..., a nanotechnology development company that is dev...lmonella announced today an update regarding its p...e Company stated that although it had received mul...d testing from its contract manufacturer, due to i...
...ing centre was Friday forced to call in police whe...ed overnight, demanded to be let in for the launch... that by Friday morning as many as two thousand pe...'s upmarket Landmark centre to buy the creation of...
Other Medicine News:Health News:Scientists Destroy Cancer Cells Using Electric Pulses 2Health News:Inaccuracies in Cardiac PET-CT Scanning 2Health News:Inaccuracies in Cardiac PET-CT Scanning 3Health News:NanoSensors Provides Update on Its Biosensor to Detect E.coli and Salmonella 2Health News:Designer Bag Launch Causes Shopping Chaos in Hong Kong 2(Date:1/8/2009)...to Identify and Validate Novel Gene Expression Bio...Gene Expression Platform , , FREMONT, Calif., J...s, Inc. (OTC Bulletin Board: WGBS), a leading deve...ing, cell biology and stem cell research systems, ...ation with the University of Texas Southwestern M...
(Date:1/8/2009)... at the initial dose in an ongoing Phase Ib trial ... after three days , , Conference Call Today at ...irstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq:...ohort of an ongoing Phase Ib clinical trial of ANA...polymerase inhibitor. ANA598 was very well-tolera...
(Date:1/7/2009)...ants Drive the Increase , , WHITE PLAINS, N.Y.,...statistics confirm that the decades-long rise in t...ting more infants than ever at increased risk of d...s. , , Nearly 543,000 babies were born too soon...lth Statistics, which today released "Births: Fina...
(Date:1/7/2009)... Tiantan Puhua Hospital Stem Cells ...dwide leader in using stem cells to effectively tr...w globally experienced additions to its medical an...pital,s treatment capabilities for growing numbers...r doctors include the distinguished Dr. Jiang Ping...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Male cyclists risk sexual problems if they don 26 23146 3Bt choose the right bike 3937 1Male cyclists risk sexual problems if they don 26 23146 3Bt choose the right bike 3937 2Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 1Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 2Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 3Johnson 26 Johnson to Host Analyst Conference Call on Second Quarter Results 23454 1RADI Medical Systems Launches Next Generation PressureWire 28R 29 Certus 6415 1RADI Medical Systems Launches Next Generation PressureWire 28R 29 Certus 6415 2[0] WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System[0] ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients[1] Preterm Births Rise 36 Percent Since Early 1980s[0] Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients
...l results from a,Phase II study presented for the ...annual meeting showed that MK-0974, an,investigati...eceptor antagonist, significantly improved migrain...lacebo, and the relief was,sustained through 24 ho...tudy. Responses specific to other measures, such a...
...irstCall/ --,Mymetics Corporation announced today ...,s HIV vaccine elicited neutralizing,IgA mucosal a...A,antibodies are considered as a possible first li...ere presented by Sylvain,Fleury, Ph.D., Mymetics, ...titled, "Without Mucosal Adjuvant, Virosomes-gp41,...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 2Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 3Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 4...White Sun light source offers the industry standar...o Kelvin color temperature at a lower price. A uni...Sun to be used with Olympus, Storz, ACMI/Circon an...s light output LED and re-settable bulb timer. The...
...NGAL ELISA Kit is intended for determination of hu...ine), tissue extracts or culture media., NGAL (n...atically increased, especially in urine, as early ... repair processes. NGAL expression in plasma or ur...
...Dual Light Head is clearly the favorite for most s... arms, the dual light heads rotate freely about th...nlimited positioning. Engineered construction prev...es ranging from minimally invasive through trauma ...
... configuration offers all the performance of a maj...ctly for use in Outpatient Settings, Minor Procedu...ng two single lights either side of the OR table i...hen combining Flat Screen LCD Monitors with the li...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |